Funder
National Research Council Canada
Canadian Institutes of Health Research Grant
Natural Sciences and Engineering Research Council of Canada
Fonds de Recherche du Québec – Santé
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference49 articles.
1. Situation Report – Ebola Virus Disease – 10 June 2016. Geneva: World Health Organization; 2016.
2. Ebola vaccine development: systematic review of pre-clinical and clinical studies, and meta-analysis of determinants of antibody response variability after vaccination;Gross;Int J Infect Dis,2018
3. Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial;Zhu;Lancet,2015
4. Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial;Zhu;Lancet,2017
5. Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: an open phase I/II trial in healthy adults in Russia;Dolzhikova;Hum Vaccin Immunother,2017
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献